ARTICLE | Management Tracks
C-suite shake ups at Voyager, Passage; plus BioNTech, Iovance, Forbion, Aelix and more
May 19, 2021 10:40 PM UTC
Andre Turenne resigned as president and CEO of Voyager Therapeutics Inc. (NASDAQ:VYGR) and Omar Khwaja stepped down as the company’s CMO and head of research development to pursue other opportunities. Chairman Michael Higgins will serve as interim CEO and board director Glenn Pierce will become interim CSO of the gene therapy company.
Gary Romano and Richard Morris stepped down as CMO and CFO, respectively, of gene therapy developer Passage Bio Inc. (NASDAQ:PASG). Chief Research and Development Officer Eliseo Salinas will serve as interim CMO. ...